Time-Varying Cardiovascular Outcomes of Sodium-Glucose Cotransporter Inhibitors in Patients with Type 2 Diabetes: A Post Hoc Analysis of Pivotal Trials Using Restricted Mean Survival Time

Ioannis Milioglou, Issam Motairek, Salil Deo, Ravi Ramani, Ian J. Neeland, Sanjay Rajagopalan, Sadeer G. Al-Kindi

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)E009491
JournalCirculation: Cardiovascular Quality and Outcomes
Volume16
Issue number3
DOIs
StatePublished - Mar 1 2023

Keywords

  • canagliflozin
  • dapagliflozin
  • empagliflozin
  • ertugliflozin
  • sodium-glucose transporter 2 inhibitor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this